Publisher: Next Move Strategy Consulting
Category: Mass Spectrometry
Category: Mass Spectrometry
Mass Spectrometry market research reports by Next Move Strategy Consulting
(2 reports matching your criteria)
-
Cancer/Tumor Profiling Market by Technology (Immunoassay, Next-generation Sequencing (NGS), Insitu Hybridization, Mass, Spectrometry, PCR, Microarray, and Others) by Biomarker Type (Genomic Biomarkers, and Protein Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, and Others), and by Application (Research Application and Clinical Application) – Global Opportunity Analysis and Industry Forecast, 2024–2030
Cancer/Tumor Profiling Market by Technology (Immunoassay, Next-generation Sequencing (NGS), Insitu Hybridization, Mass, Spectrometry, PCR, Microarray, and Others) by Biomarker Type (Genomic Biomarkers, and Protein Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, and Others), ... Read More
-
Cancer Tumor Profiling Market by Technique (genomics, proteomics, metabolomics, and epigenomics), by Technology (Immunoassay, NGS, Insitu Hybridization, Mass, Spectrometry, PCR, Microarray and Others) and by Application (Research Application and Clinical Application)- Global Opportunity Analysis and Industry Forecast 2022-2030
Cancer Tumor Profiling Market by Technique (genomics, proteomics, metabolomics, and epigenomics), by Technology (Immunoassay, NGS, Insitu Hybridization, Mass, Spectrometry, PCR, Microarray and Others) and by Application (Research Application and Clinical Application)- Global Opportunity Analysis and ... Read More